Nuvalent

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.

About NUVL

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC.

CEO

James R. Porter

CEOJames R. Porter

Employees

142

Employees142

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2017

Founded2017

Employees

142

Employees142

NUVL Key Statistics

Market cap

5.80B

Market cap5.80B

Price-Earnings ratio

-18.39

Price-Earnings ratio-18.39

Dividend yield

—

Dividend yield—

Average volume

655.10K

Average volume655.10K

High today

$82.29

High today$82.29

Low today

$80.26

Low today$80.26

Open price

$81.30

Open price$81.30

Volume

348.88K

Volume348.88K

52 Week high

$113.51

52 Week high$113.51

52 Week low

$55.54

52 Week low$55.54

Analyst ratings

100%

of 12 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own NUVL. This list is generated using Robinhood data, and it’s not a recommendation.

Eli Lilly

AMD

Taiwan Semiconductor Manu…

NVIDIA

Robinhood Markets

Microsoft

Nuvalent

Why Robinhood?

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. Show more

NUVL Key Statistics

Analyst ratings

100%

People also own

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC.